46
Views
18
CrossRef citations to date
0
Altmetric
Original Article

Transplacental effects of allopurinol on suppression of oxygen free radical production in chronically instrumented fetal lamb brains during intermittent umbilical cord occlusion

, , , , , & show all
Pages 1-7 | Published online: 03 Aug 2009

References

  • Freeman J, Nelson K Intrapartum asphyxia and cerebral palsy. Pediatrics 1988;82:240–249.
  • Blair E, Stanley F. Intrapartum asphyxia: A rare cause of cerebral palsy. J Pediatr 1988;112:515–519.
  • Clapp JF, Peress NS, Wesley M, et al. Brain damage after intermittent partial cord occlusion in the chronically instru-mented fetal lambs. Am J Obstet Gynecol 1988;159:504–509.
  • De Haan HH, Gunn AJ, Williams CE, et al. Brief repeated umbilical cord occlusions cause sustained cytotoxic cerebral edema and focal infarcts in near-term fetal lambs. Pediatr Res 1997;41:96–104.
  • Masaoka N, Hayakawa Y, Ohgame S, et al. Changes in purine metabolism and production of oxygen free radicals by intermittent partial umbilical cord occlusion in chronically instrumented fetal lambs. J Obstet Gynecol Res 1998;24:63–71.
  • Palmer C. Hypoxic-ischemic encephalopathy: Therapeutic approaches against microvascular injury, and role of neutro-phils, PAF, and free radicals. Chin Perinatol 1995;22:481–517.
  • Pourcyrous M, Leffler CW, Bada HS, et al. Brain superoxide anion generation in asphyxiated piglets and the effect of indomethacin at therapeutic dose. Pediatr Res.1993;34:366–369.
  • Betz AL. Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries. J Neurochem 1985;44:574–579.
  • Gluckman PD, Williams CE. Is the cure worse than the disease? Caveats in the move from laboratory to clinic. Dev Med Child Neurol 1992;34:1015–1018.
  • Palmer C, Vanucci RC, Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatr Res 1990;27:332–336.
  • Palmer C, Smith MB, Williams CD, et al. Allopurinol preserves cerebral energy metabolism during perinatal hy-poxic-ischemic injury and reduces brain damage in a dose dependent manner. J Cereb Blood Flow Metab 1991; 11:S144–S149.
  • Moonhouse PC, Grootvelt M, Halliwell B, et al. Allopurinol and oxypurinol are hydroxyl radical scavenger. FEBS Lett 1987;21:23–28.
  • Ko KM, Godin DV. Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem Pharmacol 1990;40: 803–809.
  • Boda D, Nemeth I, Hencz P, et al. Effect of allopurinol treatment in premature infants with idiopathic respiratory distress syndrome. Dev Pharmacol Ther 1984;7:357–367.
  • Russel GAB., Cooke RWI. Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Chi1d1995;73:F27–F31.
  • Marro PJ, Baumgart S, Delivoria-Papadopoulas M, et al. Purine metabolism and inhibition of xanthine oxidase in severly hypoxic neonates going onto extracorporeal membrane oxygenation. Pediatr Res 1997;41:513–520.
  • Palmer C, Towfighi J, Roberts SL, et al. Allopurinol administered after inducing hypoxia-ischemia reduces injury in 7-day-old rats. Pediatr Res1993;33:405–409.
  • Palmer C, Roberts RL. Delayed administration of allopurinol after cerebral hypoxia-ischemia reduced brain injury in neonatal rats. Pediatr Res 1994;41:294A.
  • Frank VB, Majidah S, Ralf MW, et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998;101:185–193.
  • Shadis M, Moison R, Steendijk P, et al. The effect of antioxidative combination therapy on post hypoxic-ischemic perfusion, metabolism, and electrical activity of the newborn brain. Pediatr Res; 44:119–124.
  • Marron PJ, Hoffmann D, Schneiderman R, et al. Effect of allopurinol on NMDA receptor modification following recurrent asphyxia in newborn piglets. Brain Res 1998;16:71–77.
  • Shadid M, Buonocore G, Groenendaal F, et al. Effect of deferoxamine and allopurinol on non-protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia. Neurosci Lett 1988;22:5–8.
  • Marro PJ, Anderson CB, Mishra OP, et al. Effect of allopurinol on hypoxia-induced modification of the NMDA receptor in newborn piglets. Neurochem Res 1999;24:1301–1306.
  • Whitelaw A. Systematic review of therapy after hypoxic-ischemic brain injury in the perinatal period. Semin Neonatol 2000;5:33–40.
  • Terzi C, Kuzu A, Asiar AK, et al. Prevention of deleterious effects of reperfusion injury using one-week high-dose allopurinol. Dig Dis Sci 2001;46:430–437.
  • Akdemir H, Asik Z, Pasaoglu H, et al. The effect of allopurinol on focal cerebral ischemia: An experimental study in rabbits. Neurosurg Rev 2001;24:131–135.
  • Borges F, Fernandes E, Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem 2002;9:195–217.
  • Peeters-Scholte C, Vant Den Tweel E, Iorol T. et al. Pharmacological interventions in the newborn piglet in the first 24 h after hypoxia-ischemia: A hemodynamic and eletrophysiological perspective. Exp Brain Res 2002;147: 200–208.
  • Whitelaw A, Thoresen M. Clinical trial of treatment after perinatal asphyxia. Curr Opin Pediatr 2002;14:664–668.
  • Kann HE, Wells JH, Galleli JF, et al. The development and use of an intravenous preparation of allopurinol. Am J Med Sci 1968;256:53–63.
  • Saliba E, Marret S. Cerebral white matter damage in the preterm infant: Pathophysiology and risk factors. Semin Neonatol 2001;6:121–133.
  • Takashima S, Tanaka K. Development of cerebrovasucular architecture and its relationship to periventricular leukomala-cia. Arch Neurol 1995;35:11–16.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.